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ABSTRACT 
Aims: First, to conduct a detailed exploration of the prospective relations between four 
commonly used anthropometric measures with incident diabetes and to examine their 
consistency across different population subgroups. Second, to compare the ability of each of 
the measures to predict five-year risk of diabetes. 
Methods: We conducted a meta-analysis of individual participant data on body mass index 
(BMI), waist circumference (WC), waist-hip and waist-height ratio (WHtR) from the Obesity, 
Diabetes and Cardiovascular Disease Collaboration. Cox proportional hazard models were 
used to estimate the association between a one standard deviation increment in each 
anthropometric measure and incident diabetes. Harrell’s concordance statistic was used to test 
the predictive accuracy of each measure for diabetes risk at five years.  
Results: Twenty-one studies with 154,998 participants and 9342 cases of incident diabetes 
were available. Each of the measures had a positive association with incident diabetes. A one 
standard deviation increment in each of the measures was associated with 64-80% higher 
diabetes risk. WC and WHtR more strongly associated with risk than BMI (ratio of hazard 
ratios: 0.95 [0.92, 0.99] - 0.97 [0.95, 0.98]) but there was no appreciable difference between 
the four measures in the predictive accuracy for diabetes at five years.  
Conclusions: Despite suggestions that abdominal measures of obesity have stronger 
associations with incident diabetes and better predictive accuracy than BMI, we found no 
overall advantage in any one measure at discriminating the risk of developing diabetes. Any 
of these measures would suffice to assist in primary diabetes prevention efforts.      
 
Keywords: diabetes; body mass index; waist circumference 
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1. INTRODUCTION 
Diseases that are strongly related to sedentary lifestyles and overconsumption of energy dense 
foods are among the leading causes of morbidity and mortality, worldwide. Among these are 
obesity and type-2 diabetes, which have both been steadily increasing in prevalence over the 
last three decades. In 2014 two in five adults were estimated to be overweight or obese [1], 
and despite the strong causal relationships between adiposity and adverse health conditions - 
in particular type 2 diabetes - relative weight status is not routinely measured or monitored in 
general practice in some countries. For example, in a recent study in Australia only 22% of 
general practice patients had their body mass index (BMI) recorded and less than 5% had their 
waist circumference (WC) measured [2]. There are several possible reasons for this, including 
time constraints during clinical visits, the perceived ‘normality’ of overweight in society and 
controversies related to the associations of overweight with health outcomes [3-5]. In 
addition, the ongoing uncertainty as to which measure of body size is most important at 
gauging an individual’s risk [6] - particularly with respect to diabetes - may also contribute to 
the lack of their monitoring in clinical practice.  
 
Aside from age, excess body weight is the strongest determinant of an individual’s risk of 
developing type 2 diabetes. Evidence from large-scale observational studies has demonstrated 
the direct association between body size (most notably, BMI) with risk of diabetes [7-8]. 
These data are supported by randomised trial evidence which has shown that moderate weight 
loss can reduce both the future risk of developing diabetes and, in some individuals, bring 
about a reversal of diabetes back to a normoglycaemic state [9-10]. In addition, measures of 
central obesity (such as WC and waist-hip ratio [WHR]) have been suggested to be even more 
strongly related to diabetes risk compared with BMI. However, whether one measure of 
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obesity is more strongly associated with incident diabetes than other ones remains unclear and 
findings from two earlier meta-analyses have reached conflicting conclusions [11-12].  
 
Given the robustness and strength of the relationship between adiposity and incident diabetes, 
a natural progression has been to determine how well these measures - either alone, or in 
combination with BMI - predict future risk of diabetes. Indeed there are several diabetes risk 
prediction tools that have incorporated one or more anthropometric measures into their 
models [13-14]. However, few prospective studies have had the ability to compare the 
predictive capability of easy to measure anthropometric measures to predict incident diabetes 
within a given time-frame. The aims of this study were, thus, two-fold: first, to conduct a 
detailed exploration of the prospective relations between four commonly used anthropometric 
measures with incident diabetes and to examine their consistency across different population 
subgroups. The second aim was to compare the ability of each of the measures to predict five-
year risk of diabetes using pooled individual-level data from prospective studies that 
contributed to the Obesity, Diabetes and Cardiovascular Disease Collaboration (ODCDC). 
 
 
2. MATERIALS AND METHODS 
The ODCDC is an international data pooling collaboration established to address outstanding 
issues of epidemiological and clinical importance regarding simple measures of obesity and 
risk of incident diabetes in diverse populations. The ODCDC database was developed from a 
cleaned and coded dataset provided by investigators of the Collaborative Study of Obesity and 
Diabetes in Adults (CODA) after obtaining permission of data use from investigators of each 
of the prospective (but not cross-sectional) studies included in CODA. Detailed information 
of the CODA project including characteristics of included studies has been published 
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elsewhere [15]. Datasets from additional studies were cleaned and coded according to the 
CODA dataset prior to merging into a master dataset. Characteristics of all included studies 
are available in Supplementary table 1. 
 
Participants with self-reported or newly diagnosed diabetes at baseline or who lacked follow-
up information on diabetes status were excluded from all analyses. BMI was calculated by 
dividing weight (kg) by the square of height (m). WC were measured using one of four 
measurement protocols (above iliac crest; midpoint between rib and iliac crest; narrowest 
waist; and immediately below the lowest rib; Supplementary table 1). WHR was calculated by 
dividing WC (cm) by hip circumference (cm). Similarly, WHtR was calculated by dividing 
WC (cm) by height (cm). Participants were considered to have incident diabetes if they were 
free from diabetes at baseline but had fasting plasma glucose ≥7.0 mmol/L, 2 hour post load 
plasma glucose ≥11.1 mmol/L, and/or reported having diabetes and/or use of anti-diabetic 
medications at follow-up. Duration of follow-up for diabetes was the time between baseline 
exam and last follow-up on diabetes status. Time to diabetes was calculated as the time 
between baseline exam and diagnosis of diabetes during a follow-up visit. For participants 
who self-reported having diabetes at follow-up and provided the age when diabetes was first 
diagnosed, time to diabetes was calculated as the difference between age at baseline and age 
at diagnosis of diabetes. Participants who were lost to follow-up or free from diabetes by the 
end of the study period were censored. 
 
2.1 Statistical analysis 
Cox proportional hazards regression models were used to regress time until diagnosis of 
diabetes against anthropometric measures at baseline. Tests for linear trend between each 
anthropometric measure and risk of diabetes were conducted by plotting hazard ratios and the 
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respective 95% confidence intervals associated with each fifth of anthropometric measure 
adjusted for baseline age, sex and study centre. Tests of nonlinearity were conducted by 
comparing the difference in -2 log likelihood between two models and chi-square 
approximation. Significance was set at p<0.05. Continuous associations between each 
anthropometric measure and diabetes were estimated by calculating the hazard ratios 
associated with one standard deviation increment. Analyses were stratified by sex and study 
centre, and adjusted for age, family history of diabetes, and smoking status (never, former, or 
current smoker). Log cumulative hazard plots were used to check the proportion hazards 
assumption. 
  
The difference in log hazard ratios between two anthropometric measures was estimated using 
bias-corrected and accelerated bootstrapping with 2000 iterations for each study in 
participants with information on all four anthropometric measures. Study-specific log hazard 
ratios were pooled using random effects meta-analysis to obtain overall sex-specific estimate 
for each anthropometric measure. I
2
 statistics were used to quantify heterogeneity. Subgroup 
analyses by baseline age (<50 years and ≥50 years), baseline fasting plasma glucose (<5.6 
mmol/L and ≥5.6 mmol/L), known diabetes rate (<5%, 5-10%, and >10%), and race/ethnicity 
(US White, US Black, US Hispanic or Mexican, US Asian or Japanese origin, and Native 
American) where study data were available. 
 
Harrell’s concordance statistics, stratified by study centre and sex, and adjusted for the above 
mentioned covariates were used to determine the predictive accuracy of each of the four 
anthropometric measures for risk of diabetes at five years. Participants who did not develop 
diabetes in the first five years from baseline were censored. Newson’s method was used to 
compute confidence intervals of c-statistics and compare the c-statistics between two 
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anthropometric measures [16]. Random effects meta-analyses were used to obtain pooled c-
statistics for each anthropometric measure and their pooled differences between two 
anthropometric measures.  
 
Analyses were repeated on participants with information on all four anthropometric measures. 
All statistical analyses were performed using Stata/IC 12.0 for Windows (Stata Corp LP., 
College Station, TX, USA). 
 
 
3. RESULTS 
3.1 Characteristics of studies 
Altogether, 21 studies with 154,998 participants (77% female), 9342 cases of incident 
diabetes and 1,522,130 person years of follow-up were available for analysis. Three studies 
each included only men or women; 17 studies collected information on all four 
anthropometric measures; and nine studies were from USA, three studies from Sweden, two 
studies each from Australia and Finland, and one study each from Brazil, France, Mauritius, 
Mexico and Nauru. Mean (standard deviation) duration of follow-up was 8.4 (4.7) years for 
men and 10.2 (3.2) years for women (Supplementary table 2). Diabetes at follow-up was more 
common in men than in women (8.0% versus 5.5%). In addition, men were younger (mean 
47.4 versus 54.2 years), more likely to be a current smoker (36.3% versus 18.9%) and with 
high blood pressure (38.2% versus 29.8%) than women. 
 
3.2 Associations between anthropometric measures and incident diabetes 
There was a clear and positive association between each of the four measures of body size 
with incident diabetes across a wide range of values for all measures (p for linear trend 
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<0.001) but the linear association seemed to plateau at high anthropometric values (p for 
nonlinearity <0.04; Figure 1). Log cumulative hazard plots showed relatively parallel lines 
among studies, hence, the proportional hazards assumption was not violated (data not shown). 
The correlation between anthropometric measures were generally high except for BMI and 
WHR (correlation of 0.3-0.7 in men and 0.2-0.6 in women; Supplementary table 3). 
 
In men, a one standard deviation increment in each of the four measures of body size was 
associated with 68-84% higher risk of diabetes in the age-adjusted model (Supplementary 
figures 1a-d). Further adjustment for family history of diabetes and smoking did not 
materially affect the strength of the age-adjusted associations (Figure 2a and Figure 2b). 
Converting to clinically meaningful changes, each 2 kg/m
2
 increment in BMI was associated 
with 31% increment in risk of diabetes (hazard ratio for the multivariable adjusted model: 
1.31 [1.24, 1.40]). Similarly, each 5 cm increment in WC was associated with 36% higher risk 
(hazard ratio 1.36 [1.31, 1.42]). Considerable heterogeneity between studies was observed for 
BMI (I
2
 = 85%) and WHR (I
2
 = 62%). Differences in hazard ratios between anthropometric 
measures were compared in participants who had information on all four anthropometric 
measures. The associations with incident diabetes were significantly stronger for BMI, WC, 
and WHtR when compared to WHR (Supplementary table 4). A significantly stronger 
association was also observed for WHtR in comparison to BMI. 
 
In women, a one standard deviation increment in each of the four measures of body size was 
associated with 64-80% higher risk of diabetes in the age-adjusted model (Supplementary 
figures 2a-d). Further adjustment for family history of diabetes and smoking slightly 
attenuated the strength of the age-adjusted associations (Figure 2a and Figure 2b). Each 2 
kg/m
2
 increment in BMI was associated with a 22% higher risk of diabetes (1.22 [1.13, 
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1.31]); and each 5 cm increment in WC was associated with a 28% higher risk (1.28 [1.18, 
1.37]). Moreover, substantial between study heterogeneity was present in all meta-analyses (I
2
 
≥83%). When the associations with incident diabetes were compared between anthropometric 
measures in participants with information on all four measures, the association was weaker 
for BMI than for WC (ratio of hazard ratios: 0.97 [0.95, 0.98]) and WHtR (0.96 [0.94, 0.98]; 
Supplementary table 4). 
 
3.3 Subgroup analyses 
Due to the high level of heterogeneity between studies for some anthropometric measures and 
diabetes risk, we conducted a series of subgroup analyses to explore possible sources of the 
heterogeneity based on age, baseline fasting plasma glucose, background rate of diabetes in 
the study population and race/ethnicity. There was evidence of an interaction with age; for a 
standard deviation increment in any of the four measures of body size, the point estimates 
were greater in individuals aged <50 years compared with those aged ≥50 years but 95% 
confidence intervals overlapped (Figure 2a). Of note, the associations between risk of diabetes 
and WC and WHtR were significantly stronger in those with fasting plasma glucose (<5.6 
mmol/L) at baseline compared with higher values (≥5.6 mmol/l). When grouped by the 
prevalence of known diabetes at baseline in the overall populations, the strength of 
association tended to be weaker for studies with higher rates of known diabetes (Figure 2a).  
Analysis by race/ethnicity suggested greater point estimates in US Whites than other 
race/ethnicity subgroups (Figure 2b). When converted to clinically meaningful changes (i.e. 2 
kg/m
2
 for BMI; 5 cm for WC), the difference in strength of association between US Whites 
and US Asian/Japanese origin became less obvious for WC (1.42 [1.28, 1.58] in US Whites 
and 1.36[1.24, 1.50] in US Asian/Japanese origin). The strength of association remained 
weakest for Native American (1.15 [1.12, 1.19]). Similar results were observed when only 
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those participants with all four anthropometric measures were analysed (Supplementary table 
5). 
 
3.4 Predictive accuracy of anthropometric measures for risk of diabetes at five years 
The predictive accuracy for five-year risk of diabetes was similar between the four 
anthropometric measures, with c-statistics, adjusted for age, family history of diabetes and 
smoking, ranging from 0.72 to 0.74 in men and was 0.74 for all four measures in women 
(Table 1). The c-statistics remained unchanged following restriction to those participants who 
had information available for all four anthropometric measures (n = 82,099). When compared 
with BMI, there was no evidence that any other measure of body size had higher predictive 
accuracy for incident diabetes (the c-statistics differed by only 0.01 unit in each case).  
 
 
4. DISCUSSION 
In this large individual participant data meta-analysis that included nearly 155,000 adults 
without diabetes at baseline and 1,522,130 person years of follow-up, each of four commonly 
used anthropometric measures had a direct and graded association with incident diabetes 
across a wide range of values. For a one standardised increment in any of the four measures 
the risk of developing diabetes was approximately 60-80% higher in men and women. In 
contrast, the InterAct Consortium, which investigated the association of BMI and WC with 
incident diabetes, reported stronger association for WC in women [17]. Although there was 
some evidence that WHtR and WC (but not WHR) were more strongly associated with 
incident diabetes compared with BMI - a finding consistent with an earlier meta-analysis [12] 
- this did not translate into higher accuracy of these measures to identify those individuals at 
greatest risk of incident diabetes at five years compared with BMI.  
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Despite no differences between the four anthropometric measures in predicting risk of 
diabetes in the current meta-analysis, some studies have suggested that there may be potential 
benefit in using information from more than one anthropometric measure rather than any one 
measure alone. For example, the EPIC Potsdam study compared the risk of type 2 diabetes in 
participants categorised by BMI-based and WC-based obesity definitions, i.e. normal weight 
with or without abdominal obesity, overweight with or without abdominal obesity, and obese 
with or without abdominal obesity [18]. The authors from that study concluded that the 
additional information conferred by WC was important in assessing the risk of diabetes in 
those classified as having normal weight (based on BMI).  
 
Worldwide, the prevalence of diabetes is rising and is estimated to increase by 55% from 
2015 to 2040 [19]; excess body weight is the single most important modifiable risk factor for 
incident type 2 diabetes and yet, monitoring of anthropometric measures and provision of 
weight loss advice where appropriate is not routinely performed in clinical practice, even in 
many higher-income countries. For example, a primary care study in the UK reported that 
90% of overweight patients, 80% of obese patients and 60% of severely obese patients did not 
receive any weight management intervention [20].
 
Similarly, a US study reported a decrease 
in weight loss counselling between 1995/96 and 2003/04 despite continual increase in obesity 
prevalence [21]. There are a myriad of possible explanations for this which include among 
other reasons, poor training in weight management counselling, low awareness of the hazards 
of additional weight gain in those already overweight, and the perceive futility of physical 
activity and dietary advice on patients’ weight [22-23]. Also, weight management is often not 
considered as a disorder that requires a use of health services. There are few health 
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professionals that have proper skills for weight management, and many health insurance 
schemes do not consider weight management for reimbursement, except in morbid obesity. 
 
Our findings have direct implications for diabetes prevention in clinical practice by 
supporting the continued monitoring of a patient’s body size and where appropriate providing 
advice to either lose or maintain weight as a means of minimising future risk of diabetes. The 
question of how best to measure it - be it BMI, WC or WHR - appears largely irrelevant. But 
by not doing so, health professionals risk losing an important opportunity at providing an 
early diabetes prevention intervention such as referral to weight loss counselling or 
pharmacotherapy - to mitigate future risk of diabetes in their patients. Such interventions have 
been proven efficient in multiple controlled trials, and are thus evidence based. 
 
The major strength of our study was the use of individual participant data from 21 studies 
around the world. Unlike a meta-analysis of published studies, we were able to standardise 
study-specific estimates prior to data pooling. In a traditional systematic review and meta-
analysis, the level of adjustments made can differ between studies; hence, combining study-
specific estimates that vary in the level of adjustment can distort the pooled estimate. 
Nevertheless, a limitation of our study was the high between study heterogeneity. Meta-
regression suggested that baseline age, BMI and fasting plasma glucose only explained the 
between study differences in some of the analyses (data not shown). Unlike failure times for 
cardiovascular disease events or death, the time to diabetes used here is approximate as there 
was no date at diagnosis of diabetes unless it was diagnosed during a follow-up visit. 
Although 37% of participants did not have information on family history of diabetes, similar 
results were observed when the age-adjusted analysis was repeated on those participants 
included in the multivariable adjusted model. In addition, our analysis by race/ethnicity 
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subgroups was based on data from 40% of participants as the dataset obtained from CODA 
only included information on race/ethnicity in US studies; we included participants from the 
Mexico study in the US Hispanic subgroup and participants with Japanese origin from the 
Brazil study in the US Asian subgroup. Since previous studies have suggested that the risk of 
type 2 diabetes varies by ethnicity [24], we believe it is more appropriate to report results by 
race/ethnicity derived from 40% of participants rather than by geographical region where 
study data were collected. Participants were predominantly women, nevertheless, data from 
35,000 male participants were used to derive sex-specific estimates. Although four different 
WC measurement protocols were used in the studies, results remained unchanged for WC and 
WHtR when WC was standardised according to WC measurement protocol [25]. 
 
In summary, the risk of developing diabetes over a five year period associated with greater 
level of adiposity is substantial irrespective of how these differences are measured. Despite 
some earlier evidence to suggest that abdominal surface measures of central adiposity have 
stronger associations with incident diabetes and may have better predictive accuracy than 
BMI, we found none of the four measures to be superior at predicting risk of diabetes. Health 
personnel should continue to be encouraged to include routine measurement and monitoring 
of their patient’s adiposity status irrespective of their current body size, as part of a general 
diabetes preventive approach.  
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FIGURE LEGEND 
Figure 1: Age, sex and study adjusted hazard ratios for incident diabetes by fifths for a) body 
mass index (BMI); b) waist circumference (WC); c) waist-hip ratio (WHR); d) waist-height 
ratio (WHtR) 
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Figure 2a: Age, sex, family history of diabetes and smoking adjusted hazard ratios for 
incident diabetes associated with one standard deviation increment in each anthropometric 
measure by sex*, baseline age
†
, fasting plasma glucose, and known diabetes rate subgroups 
BMI = body mass index; WC = waist circumference; WHR = waist-hip ratio; WHtR = waist-
height ratio; CI = confidence intervals 
*Not adjusted for sex 
†Not adjusted for age 
 
Figure 2b: Age, sex, family history of diabetes and smoking adjusted hazard ratios for 
incident diabetes associated with one standard deviation increment in each anthropometric 
measure by race/ethnicity subgroup 
BMI = body mass index; WC = waist circumference; WHR = waist-hip ratio; WHtR = waist-
height ratio; CI = confidence intervals 
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Table 1: Random effects pooled c-statistics* for predicting 5 year risk of incident diabetes by sex 
Anthropometric 
measure 
All participants Participants with data on all 
four measures 
Difference between BMI and each abdominal 
measure 
N c-statistics (95% CI) N c-statistics (95% CI) N Difference in c-statistics (95% CI) 
Men   14994    
BMI 20272 0.73 (0.69, 0.77)  0.72 (0.69, 0.76)  - 
WC 20296 0.74 (0.70, 0.77)  0.74 (0.69, 0.78) 20236 0.01 (0.00, 0.02) 
WHR 15021 0.72 (0.67, 0.77)  0.72 (0.67, 0.77) 14994 -0.01 (-0.04, 0.01) 
WHtR 20298 0.74 (0.70, 0.78)  0.74 (0.70, 0.78) 20239 0.01 (0.00, 0.02) 
Women   67105    
BMI 67925 0.74 (0.65, 0.84)  0.74 (0.65, 0.84)  - 
WC 68228 0.74 (0.64, 0.84)  0.74 (0.64, 0.85) 67688 0.00 (0.00, 0.00) 
WHR 67544 0.74 (0.61, 0.86)  0.74 (0.61, 0.87) 67105 -0.01 (-0.02, 0.01) 
WHtR 68238 0.74 (0.65, 0.84)  0.74 (0.65, 0.84) 67734 0.00 (0.00, 0.01) 
BMI = body mass index; WC = waist circumference; WHR = waist-hip ratio; WHtR = waist-height ratio; CI = confidence intervals; 
*C-statistics adjusted for age, family history of diabetes and smoking
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Highlight 
 Waist circumference and waist-height ratio were more strongly associated with 
incident diabetes risk than body mass index 
 No overall difference between the measures in the predictive accuracy of diabetes at 
five years 
 No overall advantage in using one measure over another 
 Health practitioners should continue to be encouraged to include routine measurement 
and monitoring of their patient’s adiposity status irrespective of their current body 
size, as part of a general approach to diabetes prevention. 
 
